Market Research Logo
Publisher: Aruvian's R'search
Category: Biotechnology

Biotechnology market research reports by Aruvian's R'search

(7 reports matching your criteria)
  • United States Biotechnology Industry - Porter’s Five Forces Strategy Analysis

    ... processes that are relieving human suffering, improving health, and increasing the quality of life for the world’s citizens. The majority of U.S. biotechnology firms are pursuing markets in human health care. Aruvian's Research analyzes the ... Read More

  • Analysis of Gilead Sciences

    ... company is known for its HIV products, cardiovascular products and respiratory products. The company has approved products for the treatment of Hepatitis B & C, HIV/AIDS, fungal infections and influenza. Aruvian Research presents Analysis of ... Read More

  • Japan’s Biotechnology Industry - Porter’s Five Forces Strategy Analysis

    ... other international companies, the Japanese biotech market has witnessed a surge in business activity that has actively expanded the industry in last couple of years. In fact, the Abe government in 2014 announced that it ... Read More

  • Analyzing the Global Biotechnology Industry 2015

    ... for development in the global biotechnology industry. With public companies achieving double digit growth and there being a sharp rise in funds raised for developing new products and services in the industry, the global biotech ... Read More

  • Analysis of Agenus Inc

    ... of various cancers and infectious diseases. The company has in place a strong research and development team along with a strong portfolio of intellectual properties. Aruvian’s R’search presents Analysis of Agenus Inc. A complete and ... Read More

  • Analysis of Genentech, Inc.

    ... as cancer, angiogenic disorders, immunological diseases and others. Rituxan, Herceptin, Xolair, Activase, etc., are some of the company's major products that are well known around the world. Aruvian’s R’search presents Analysis of Genentech Inc. A ... Read More

  • Analysis of Amgen Inc.

    ... company markets primarily recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN, which selectively ... Read More

Research Assistance

Biotechnology market research reports by Aruvian's R'search

Join Alert Me Now!

Sign Up

Find out more on our blog